Abiraterone Tablets
250mg
Works by reducing the production of testosterone throughout your body to slow or stop cancer cell growth.
Oncology Support Medications
Oncology support medicines include hormone therapies, targeted agents, chemotherapy-related medicines, and supportive treatments used in cancer care. This category is informational only: cancer treatment depends on diagnosis, staging, biomarkers, and specialist oversight.
Anastrozole Tablets
1mg
The product is utilized to alleviate hormonal signals influencing tissue growth in specific patient populations.
Arimidex
1mg
Arimidex is developed to target hormone-dependent breast cancer and is formulated to alleviate tumour progression.
Armotraz
1mg
Indicated to help manage oestrogen-dependent conditions by supporting the suppression of excess hormone production in postmenopausal patients.
Aromasin
25mg
Developed to target oestrogen production and indicated to support cancer treatment, this inhibitor is utilized to address hormone-sensitive malignancies.
Bicalutamide Tablets
50mg
Developed to target prostate cancer activity, this medication is indicated to support the management of androgen-dependent disease progression in adult males.
Capecitabine Tablets
500mg
Utilized to target malignant cell proliferation, this chemotherapy agent is indicated to support the management of advanced colorectal, breast, and gastric carcinomas.
Capnat
500mg
Developed to target cancerous growths by utilizing systemic conversion to therapeutic agents that inhibit DNA synthesis.
Casodex
50mg
Designed to target tumour growth, indicated to manage advanced prostate cancer effectively.
Chlorambucil Tablets
2 · 5mg
Developed to target malignancy, utilized to manage symptoms of chronic lymphoid conditions.
Cyclophosphamide Tablets
50mg
Formulated to treat lymphoid malignancies; indicated to target rapidly dividing cells to alleviate disease progression.
Cytoxan
50mg
Utilized to target malignant neoplasms to alleviate disease progression and cell proliferation.
Dasatinib Solution
50mg
Developed to manage chronic myeloid leukaemia; indicated to support effective leukaemia control.
Efudex
1 · 5%
utilized to target actinic keratosis and intended to support the reduction of cancerous skin cell proliferation.
Fluorouracil Cream
1 · 5%
This topical treatment is indicated to target precancerous skin lesions and certain carcinomas, formulated to alleviate damaged cell growth.
Hydrea
500mg
Developed to alleviate conditions involving abnormal blood cell growth to address long-term stability and symptom control.
Hydroxyurea Tablets
500mg
Formulated to target cancerous cell growth and indicated to support blood count regulation, this agent is utilized to manage specific haematologic conditions.
Lenalidomide Capsules
10mg
Indicated to address haematological malignancies to support cancer remission.
Leukeran
2 · 5mg
Utilized to manage specific types of blood cancers, formulated to slow the progression of malignant cellular growth in the lymphatic system.
Methotrexate Tablets
2.5mg
Utilized to manage autoimmune responses and indicated to alleviate inflammation-related tissue damage effectively.
Tamoxifen Tablets
10 · 20mg
Indicated to support to mitigate breast cancer progression, utilized in patients requiring hormonal manipulation for effective disease management.
Thalix
50 · 100mg
formulated to alleviate symptoms of multiple myeloma to support patient stabilization.
What this category helps you sort out
Cancer medicines are selected for the cancer type, receptor status, genetic markers, spread, previous treatment, organ function, and treatment goal. Two products in the same category can have completely different roles.
Some medicines aim to slow cancer growth, some block hormones, some target cell-signalling pathways, and others manage symptoms or treatment complications. The detail belongs in the individual product plan.
How to compare options
- Identify whether the medicine is anticancer treatment, hormone therapy, targeted therapy, chemotherapy, or supportive care.
- Check monitoring needs such as blood counts, liver tests, kidney tests, heart checks, infection risk, or pregnancy prevention.
- Review food restrictions, handling precautions, missed-dose instructions, and interaction warnings.
- Do not use oncology medicines outside the treatment plan agreed with the oncology team.
Common medication groups
Hormone therapies
Hormone-sensitive cancers may be treated by lowering hormone production or blocking hormone receptors. Menopause symptoms, bone health, clot risk, and fertility can be relevant.
Targeted agents
Targeted therapies act on specific cancer pathways or mutations. They often require biomarker testing and close monitoring for organ-specific side effects.
Chemotherapy and supportive medicines
Chemotherapy affects rapidly dividing cells and can lower blood counts or cause nausea, infection risk, and organ effects. Supportive medicines help manage complications but still require clear instructions.
Safety notes for this category
Fever during cancer treatment, uncontrolled vomiting, severe diarrhoea, breathlessness, bleeding, confusion, or signs of infection should be treated as urgent.
Oncology medicines can interact with supplements, antifungals, antibiotics, anticoagulants, acid reducers, and many common prescriptions.
Important Safety Information
Oncology medicines are specialist treatments with diagnosis-specific risks and monitoring. This page is educational and does not replace oncology guidance, treatment protocols, emergency instructions, or product labeling.